Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
FRST Transcript
Primis Financial Corp. (FRST) Q4 2025 Earnings Call Transcript
Positive1-30
The earnings call highlights strong financial metrics, including improved net interest margin, significant loan growth, and increased mortgage revenue. The Q&A section reinforces positive sentiment with expected growth in warehouse balances and loan production. Despite some unclear management responses, the company's strategic plans for ROA and expense management are well-received. The lack of negative surprises and optimistic guidance supports a positive stock price reaction.
Primis Financial Corp. (FRST) Q3 2025 Earnings Call Transcript
Positive10-24
The earnings call summary reflects strong financial performance with significant improvements in net earnings, EPS, and ROA. The company has a clear strategy for cost management and deposit growth, with a focus on maintaining profitability. The Q&A section indicates confidence in loan growth and deposit management, although some details were vague. Overall, the positive financial results and optimistic outlook for future growth suggest a likely positive stock price movement, especially considering the potential for increased margins and growth in digital banking.
Primis Financial Corp. (FRST) Q2 2025 Earnings Call Transcript
Positive7-25
The earnings call highlights strong financial performance, with significant net income, improved margins, and robust mortgage volume growth. The Q&A section suggests positive growth expectations for Panacea and the mortgage warehouse, with anticipated NIM improvements. Although management avoided specifics on local vs. digital growth, overall guidance remains optimistic. The strategic focus on cost reduction and asset growth, coupled with a low cost of deposits, supports a positive outlook. Despite some uncertainties, the overall sentiment is positive, anticipating a stock price increase of 2% to 8%.
Earnings call transcript: Primis Financial Q1 2025 misses EPS forecast
Unknown4-30
The earnings call presents a mixed picture: while there are positive aspects such as improved net interest margin and loan growth, there are significant concerns including high charge-offs, consumer loan volatility, and regulatory pressures. The Q&A section reveals uncertainties around Panacea deconsolidation and potential challenges in Q2. Despite some positive guidance, the lack of a share repurchase or dividend program and unclear management responses temper the outlook. Overall, the sentiment is neutral due to the balancing of positive financial metrics against significant risks and uncertainties.
FRST Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.